LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

Nicoletta Colombo, Angiolo Gadducci, Jalid Sehouli, Elena Biagioli, G-B. Nyvang, Salomé Riniker, Ana Montes, Nelleke Ottevanger, Alain G. Zeimet, I. Vergote, G. Funari, Alessandra Baldoni, Germana Tognon, Andrea De Censi, Cristina Churruca Galaz, Radoslav Chekerov, Johanna Mäenpää, Eliana Rulli, Roldano Fossati, Andrés Poveda